EUTM file information

003102829

THE DRIVE TO DISCOVER... THE DISCIPLINE TO DELIVER

March 19, 2003

Trademark Summary

The trademark application THE DRIVE TO DISCOVER... THE DISCIPLINE TO DELIVER was filed by Biogen MA Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on January 30, 2005, and it was registered by office on June 20, 2005 without any oppositions.

The application was filed in English (French was selected as the second language).

The renewal of the trademark was recorded by the office on January 25, 2014.

of the trademark registration was recorded on January 25, 2014. Change of name and address of the trademark registration was recorded on August 8, 2004. Change of name and address of the trademark registration was recorded on March 24, 2006. Appointment and Replacement of representative of the trademark registration was recorded on September 23, 2007. Change of name and professional address of the trademark registration was recorded on November 2, 2008. Appointment and Replacement of representative of the trademark registration was recorded on January 18, 2009. Change of name and professional address of the trademark registration was recorded on November 16, 2011.

Goods And Services

  • The mark was filed in class 16 with following description of goods:
    1. Paper, cardboard and goods made from these materials
    2. Paper, cardboard and goods made from these materials, namely, printed matter, advertisements, brochures, circulars, folders, reports, stickers, notebooks, stationery, pens, posters, banners, monographs, slides, audiovisual presentation materials
    3. Teaching materials concerning pharmaceuticals and biologic agents for the prevention and treatment of human diseases in the fields of autoimmunity, inflammation, oncology, fibrosis, and neurodegeneration.
  • The mark was filed in class 42 with Pharmaceutical, biopharmaceutical, and health care research and development services and pharmaceutical, biopharmaceutical, and health care research and development services, namely, basic and applied research and product development and manufacturing of pharmaceuticals and biologic agents for the prevention and treatment of human diseases in the fields of autoimmunity, inflammation, oncology, fibrosis, and neurodegeneration..